- Home
- CLRO vs MBRX Comparison
CLRO vs MBRX Comparison
Compare CLRO & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- MBRX
- Stock Information
- Founded
- CLRO 1983
- MBRX 2015
- Country
- CLRO United States
- MBRX United States
- Employees
- CLRO 80
- MBRX N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- MBRX Health Care
- Exchange
- CLRO Nasdaq
- MBRX Nasdaq
- Market Cap
- CLRO 12.5M
- MBRX 12.4M
- IPO Year
- CLRO N/A
- MBRX 2016
- Fundamental
- Price
- CLRO $0.50
- MBRX $0.87
- Analyst Decision
- CLRO
- MBRX Strong Buy
- Analyst Count
- CLRO 0
- MBRX 3
- Target Price
- CLRO N/A
- MBRX $17.33
- AVG Volume (30 Days)
- CLRO 59.0K
- MBRX 492.8K
- Earning Date
- CLRO 05-19-2025
- MBRX 05-09-2025
- Dividend Yield
- CLRO 103.39%
- MBRX N/A
- EPS Growth
- CLRO N/A
- MBRX N/A
- EPS
- CLRO N/A
- MBRX N/A
- Revenue
- CLRO $11,386,000.00
- MBRX N/A
- Revenue This Year
- CLRO N/A
- MBRX N/A
- Revenue Next Year
- CLRO N/A
- MBRX N/A
- P/E Ratio
- CLRO N/A
- MBRX N/A
- Revenue Growth
- CLRO N/A
- MBRX N/A
- 52 Week Low
- CLRO $0.43
- MBRX $0.40
- 52 Week High
- CLRO $1.40
- MBRX $5.47
- Technical
- Relative Strength Index (RSI)
- CLRO 42.24
- MBRX 44.16
- Support Level
- CLRO $0.45
- MBRX $0.80
- Resistance Level
- CLRO $0.54
- MBRX $1.05
- Average True Range (ATR)
- CLRO 0.07
- MBRX 0.10
- MACD
- CLRO -0.00
- MBRX 0.01
- Stochastic Oscillator
- CLRO 30.43
- MBRX 52.05
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.